| 商品名称 | Purevax RCPCh FeLV |
|---|
| 适用类别 | Veterinary |
|---|
| 治疗领域 | |
|---|
| 通用名/非专利名称 | vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia, feline leukeamia and feline Chlamydophila infections |
|---|
| 活性成分 | attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), attenuated Chlamydophila felis (90 |
|---|
| 产品号 | EMEA/V/C/000085 |
|---|
| 患者安全信息 | no |
|---|
| 授权状态 | Authorised |
|---|
| ATC编码 | |
|---|
| 是否额外监管 | no |
|---|
| 是否仿制药 | no |
|---|
| 是否生物类似药 | no |
|---|
| 是否附条件批准 | no |
|---|
| 是否特殊情形 | no |
|---|
| 是否加速审评 | no |
|---|
| 是否罕用药 | no |
|---|
| 批准上市日期 | 2005/02/23 |
|---|
| 上市许可持有人/公司名称 | Boehringer Ingelheim Vetmedica GmbH |
|---|
| 兽用药物治疗分组 | Immunologicals for felidae, |
|---|
| 决定日期 | 2022/02/17 |
|---|
| 修订号 | 15 |
|---|
| 适应症 | Active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against Chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.Onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, Chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.The duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components. |
|---|
| 适用物种 | Cats |
|---|
| 兽用药物ATC编码 | QI06AJ05 |
|---|
| 首次发布日期 | 2015/05/05 |
|---|
| 修订日期 | 2022/04/11 |
|---|
| 产品信息 | https://www.ema.europa.eu/en/documents/product-information/purevax-rcpch-felv-epar-product-information_en.pdf |
|---|
| 公共评估报告 | https://www.ema.europa.eu/en/medicines/veterinary/EPAR/purevax-rcpch-felv |
|---|